A Subset of Highly Effective Propafenone-Type Multidrug Resistance Modulators Lacks Effects on Cardiac Action Potential and Mechanical Twitch Parameters of Rat Papillary Muscles
- 1 November 2003
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 307 (2) , 589-596
- https://doi.org/10.1124/jpet.103.052993
Abstract
In this study, we tested a series of 12 previously identified, highly effective propafenone-type multidrug resistance (MDR) modulators for their possible undesirable effects on cardiac tissue. We used rat papillary muscle preparations and quantitatively determined the potency of these substances to block action potential (AP) upstroke velocity (Vmax) and to prolong APD50. Simultaneously, the effects on isometric twitch parameters were evaluated. Concentration-response curves were obtained for all parameters. Within a subset of the compounds, we found a significant rank correlation (r′ = 0.87; p < 0.05) between potencies to block Vmax (kiVmax) and to inhibit daunomycin efflux in MDR cells (IC50). Surprisingly, the most lipophilic compounds with additional aromatic side chains completely lacked effects on AP and mechanical twitch parameters, although they are the most effective MDR modulators. Additional structural modifications such as fluoride substitution of the aromatic ring, introduction of arylpiperazine or piperidine side chains, as well as modifying the hydrogen bond acceptor strength of the carbonyl group did not reestablish cardiac side effects. In contrast, when these substances were truncated at the phenylpropiophenone moiety of the propafenone core structure, cardiac effects reoccurred. We conclude that aromatic substituents in the vicinity of the nitrogen atom prevent interaction with ion channels, likely due to steric hindrance, and are thus a prerequisite for eliminating unwanted cardiac effects.This publication has 23 references indexed in Scilit:
- ABC transporters: physiology, structure and mechanism – an overviewResearch in Microbiology, 2001
- Propafenone Inhibition of Human Atrial Myocyte Repolarizing CurrentsJournal of Molecular and Cellular Cardiology, 1998
- A Structure−Activity Relationship Study of Novel Phenylacetamides Which Are Sodium Channel BlockersJournal of Medicinal Chemistry, 1996
- Synthesis, Pharmacologic Activity, and Structure-Activity Relationships of a Series of Propafenone-Related Modulators of Multidrug ResistanceJournal of Medicinal Chemistry, 1995
- Significance of Classifying Antiarrhythmic Actions Since the Cardiac Arrhythmia Suppression TrialThe Journal of Clinical Pharmacology, 1991
- Effects of propafenone on electrical and mechanical activities of single ventricular myocytes isolated from guinea‐pig heartsBritish Journal of Pharmacology, 1989
- Inhibitory effects of diprafenone stereoenantiomers on cardiac Na+ channelsEuropean Journal of Pharmacology, 1988
- Nonlinear relation between Vmax and INa in canine cardiac Purkinje cells.Circulation Research, 1988
- Block of cardiac sodium channels by antiarrhythmic drugs.Japanese Circulation Journal, 1988
- Block of sodium currents by antiarrhythmic agents: Analysis of the electrophysiologic effects of propafenone in heart muscleThe American Journal of Cardiology, 1984